WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007081897) FUSED TRIAZOLE TACHYKININ RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2007/081897 International Application No.: PCT/US2007/000434
Publication Date: 19.07.2007 International Filing Date: 05.01.2007
IPC:
A61K 31/503 (2006.01)
Applicants: DEVITA, Robert, J.[US/US]; US (UsOnly)
YOUNG, Jonathan, R.[US/US]; US (UsOnly)
MERCK & CO., INC.[US/US]; 126 East Lincoln Avenue Rahway, NJ 07065-0907, US (AllExceptUS)
Inventors: DEVITA, Robert, J.; US
YOUNG, Jonathan, R.; US
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue Rahway, NJ 07065-0907, US
Priority Data:
60/757,94111.01.2006US
Title (EN) FUSED TRIAZOLE TACHYKININ RECEPTOR ANTAGONISTS
(FR) ANTAGONISTES DES RÉCEPTEURS DES TACHYKININES À NOYAUX TRIAZOLES FUSIONNÉS
Abstract:
(EN) The present invention is directed to certain fused triazole compounds which are useful as neurokinin-1 (NK-I) receptor antagonists, and inhibitors of tachykinin and in particular substance P- The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.
(FR) La présente invention concerne certains composés de triazoles fusionnés qui sont utiles comme antagonistes des récepteurs de la neurokinine 1 (NK-I), ainsi que comme inhibiteurs de la tachykinine et en particulier de la substance P. L'invention concerne également des formulations pharmaceutiques comprenant ces composés en tant que principes actifs, ainsi que l'utilisation des composés et de leurs formulations dans le traitement de certains troubles, comprenant les vomissements, l'incontinence urinaire, la dépression et l'anxiété.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)